Economic implications of growth hormone use in patients with short bowel syndrome

Author： Migliaccio-Walle Kristen   Caro J. Jaime   Möller Jörgen  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.10, 2006-10, pp. : 2055-2063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatropin in short bowel syndrome: opening the door to trophic factor use

By DiBaise John K  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 55-67

Future Medicine

Access to resources Recommend Favorite

Clinical Spectrum of the Syndrome of Growth Hormone Insensitivity

By  

ACTA PAEDIATRICA, Vol. 80, Iss. S377, 1991-08 ,pp. : 87-90

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical effectiveness and economic costs of group versus one‐to‐one education for short‐chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

By  

JOURNAL OF HUMAN NUTRITION & DIETETICS (ELECTRONIC), Vol. 28, Iss. 6, 2015-12 ,pp. : 687-696

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leukemic Cluster Growth in Culture Is an Independent Risk Factor for Acute Myeloid Leukemia and Short Survival in Patients with Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 226-235

Karger

Access to resources Recommend Favorite

Regulation of Growth Hormone Secretion in Patients with Growth Hormone Insensitivity

By  

ACTA PAEDIATRICA, Vol. 80, Iss. S377, 1991-08 ,pp. : 92-95

John Wiley & Sons Inc

Access to resources Recommend Favorite